Replies to post #395999 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

CEO Ehlich is the "who's that".
"Surrendered" is the term used in the 8K filed by the Company:
"On December 30, 2022, Leo Ehrlich, Chief Executive Officer of Innovation Pharmaceuticals Inc. (the “Company”), surrendered 11,307,527 shares of the Company’s Class B common stock to the Company for individual tax planning purposes. Mr. Ehrlich received no consideration for the surrender of the shares."
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001355250/000147793223000090/ipix_8k.htm

"is that a way of saying he gave up"?
That's left for the reader to decide, but it seems to be the exact opposite of someone building "a nice large position that know(s) something we don’t know".

No one bought them.